Naja atra venom peptide reduces pain by selectively blocking the voltage-gated sodium channel Nav1.8
Naja atra venom peptide reduces pain by selectively blocking the voltage-gated sodium channel Nav1.8
复制标题
眼镜蛇毒肽通过选择性阻断电压门控钠通道 Nav1.8 来减轻疼痛
DOI:
10.1074/jbc.ra118.007370
复制
发表时间:
2019-02
影响因子:
4.8
通讯作者:
Liu Zhonghua
中科院分区:
文献类型:
--
作者:
Zhang Fan;Zhang Changxin;Xu Xunxun;Zhang Yunxiao;Gong Xue;Yang Zuqin;Zhang Heng;Tang Dongfang;Liang Songping;Liu Zhonghua
The voltage-gated sodium channel Nav1.8 is preferentially expressed in peripheral nociceptive neurons and contributes to inflammatory and neuropathic pain. Therefore, Nav1.8 has emerged as one of the most promising analgesic targets for pain relief. Using large-scale screening of various animal-derived toxins and venoms for Nav1.8 inhibitors, here we identified μ-EPTX-Na1a, a 62-residue three-finger peptide from the venom of the Chinese cobra (Naja atra), as a potent inhibitor of Nav1.8, exhibiting high selectivity over other voltage-gated sodium channel subtypes. Using whole-cell voltage-clamp recordings, we observed that purified μ-EPTX-Na1a blocked the Nav1.8 current. This blockade was associated with a depolarizing shift of activation and repolarizing shift of inactivation, a mechanism distinct from that of any other gating modifier toxin identified to date. In rodent models of inflammatory and neuropathic pain, μ-EPTX-Na1a alleviated nociceptive behaviors more potently than did morphine, indicating that μ-EPTX-Na1a has a potent analgesic effect. μ-EPTX-Na1a displayed no evident cytotoxicity and cardiotoxicity and produced no obvious adverse responses in mice even at a dose 30-fold higher than that producing a significant analgesic effect. Our study establishes μ-EPTX-Na1a as a promising lead for the development of Nav1.8-targeting analgesics to manage pain.
登录
查看更多内容
影响因子:
5
作者:
Zhonglin Han;Yu Jiang;Feng Xiao;K. Cao;Dao-wu Wang
通讯作者:
Zhonglin Han;Yu Jiang;Feng Xiao;K. Cao;Dao-wu Wang
影响因子:
4.6
作者:
Tang C;Zhou X;Zhang Y;Xiao Z;Hu Z;Zhang C;Huang Y;Chen B;Liu Z;Liang S
通讯作者:
Liang S
DOI:
10.1155/2012/364741
发表时间:
2012
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
作者:
Huang CC;Hsu MC;Huang WC;Yang HR;Hou CC
通讯作者:
Hou CC
DOI:
10.1523/jneurosci.23-01-00158.2003
发表时间:
2003-01
期刊:
The Journal of Neuroscience
影响因子:
--
作者:
M. Gold;D. Weinreich;Chang-Sook Kim;Ruizhong Wang;J. Treanor;F. Porreca;J. Lai
通讯作者:
M. Gold;D. Weinreich;Chang-Sook Kim;Ruizhong Wang;J. Treanor;F. Porreca;J. Lai
影响因子:
4.8
作者:
Po-long Wu;Shao‐Chen Lee;Chia-Chen Chuang;S. Mori;N. Akakura;Wen‐guey Wu;Y. Takada
通讯作者:
Po-long Wu;Shao‐Chen Lee;Chia-Chen Chuang;S. Mori;N. Akakura;Wen‐guey Wu;Y. Takada